our department has experience in the treatment 200 melanoma patients with cellular vaccination and in the preparation of primary tumor cell lines from various tumors including rcc. interestingly immune modulators such as antictla 4 ab have demonstrated impressive activity in patients previously vaccinated with cellular vaccinations.